October 20, 2016 7:07 PM ET

Healthcare Equipment and Supplies

Company Overview of Bracco S.p.A.

Company Overview

Bracco S.p.A., through its subsidiaries, provides diagnostic imaging, pharmaceutical products, and other healthcare services. It offers diagnostic imaging products, including contrast agents, medical devices, and injectors for administering contrast agents; optimization of clinical protocols, designing of solution for applications and workflow improvement, and development of contrast quantification software; and other customer care services. The company also provides prescription pharmaceutical products for the field of gastroenterology and endocrinology, as well as neurology, gynecology, cardiology, and pediatrics; and over the counter drugs, such as vitamin C supplements, eye drops, and ot...

Via Egidio Folli 50- I

Milan, MI 20134


Founded in 1927


39 02 21771


39 02 21 77 21 77

Key Executives for Bracco S.p.A.

Chairman, Chief Executive Officer and President
Age: 75
Head of The Global Business Unit Imaging of Bracco Imaging
Director of Bracco Research SA
General Manager of Operations At Bracco Imaging Spa
Compensation as of Fiscal Year 2016.

Bracco S.p.A. Key Developments

Apricus Biosciences, Inc. Launches Vitaros, Topical Treatment for Erectile Dysfunction, or ED, in Italy by Bracco SpA

Apricus Biosciences, Inc. has announced the launch of Vitaros, a topical treatment for erectile dysfunction, or ED, in Italy by Bracco SpA. Vitaros, Apricus' novel topical on-demand treatment for erectile dysfunction, or ED, is also marketed under the trademark Vytaros in Belgium and Virirec in Spain. This is the seventh country in the European Union in which the product has been launched, including France, Italy, Germany, the UK, Spain, Belgium and Sweden. In total, Vitaros is currently approved under the European Decentralized Procedure ("DCP") in twenty-two countries, of which fourteen have further approved Vitaros for commercialization at the national phase level of the DCP approval process. As another contributor towards the positive momentum of commercialization by partners, which recently produced 103% growth in units quarter over quarter, Bracco plans to implement a strong promotional strategy targeted at physicians across Italy. In December 2010, Apricus signed an exclusive license agreement with Bracco to market Vitaros, in Italy, Vatican City and San Marino (the "Territory"). Under the terms of the agreement, Apricus has received $1.3 million in up-front and milestone payments from Bracco. Apricus is also eligible to receive milestone payments on future sales, plus double-digit tiered royalties based on Bracco's net sales of the product in the Territory. In exchange, Bracco has the exclusive right to commercialize Vitaros in the Territory. In addition, Bracco has agreed to certain minimum marketing commitments for Vitaros.

Similar Private Companies By Industry

Company Name Region
ACEA Medica S.r.l. Europe
ALSA apparecchi medicali s.r.l. Europe
Altay Scientific SpA Europe
AMS - Analyzer Medical System S.r.l. Europe
Angiodroid srl Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Bracco S.p.A., please visit corporate.bracco.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.